IPA is a software and content solution that provides unique insights and understanding of complex biological and chemical systems at the core of life science research.
IPA is deployed in all major pharmaceutical companies and in hundreds of biotechnology companies and academic institutions globally.
It supports analysis of data from all experimental platforms and is used at all stages of the drug discovery and development process, including target identification and validation, identification of biomarkers, predictive toxicology, and pharmacogenomics.
With the extended and renewed agreement, Wyeth's research and development teams will continue to utilize IPA in multiple research areas, including its pharmacogenomics group that focuses on novel approaches to identifying biomarkers.
Read the full report.
Comment Preview